Cargando…
ErbB3-Targeting Oncolytic Adenovirus Causes Potent Tumor Suppression by Induction of Apoptosis in Cancer Cells
Cancer is a multifactorial and deadly disease. Despite major advancements in cancer therapy in the last two decades, cancer incidence is on the rise and disease prognosis still remains poor. Furthermore, molecular mechanisms of cancer invasiveness, metastasis, and drug resistance remain largely elus...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266575/ https://www.ncbi.nlm.nih.gov/pubmed/35806132 http://dx.doi.org/10.3390/ijms23137127 |
_version_ | 1784743501188038656 |
---|---|
author | Jung, Bo-Kyeong Kim, Young Jun Hong, JinWoo Chang, Han-Gyu Yoon, A-Rum Yun, Chae-Ok |
author_facet | Jung, Bo-Kyeong Kim, Young Jun Hong, JinWoo Chang, Han-Gyu Yoon, A-Rum Yun, Chae-Ok |
author_sort | Jung, Bo-Kyeong |
collection | PubMed |
description | Cancer is a multifactorial and deadly disease. Despite major advancements in cancer therapy in the last two decades, cancer incidence is on the rise and disease prognosis still remains poor. Furthermore, molecular mechanisms of cancer invasiveness, metastasis, and drug resistance remain largely elusive. Targeted cancer therapy involving the silencing of specific cancer-enriched proteins by small interfering RNA (siRNA) offers a powerful tool. However, its application in clinic is limited by the short half-life of siRNA and warrants the development of efficient and stable siRNA delivery systems. Oncolytic adenovirus-mediated therapy offers an attractive alternative to the chemical drugs that often suffer from innate and acquired drug resistance. In continuation to our reports on the development of oncolytic adenovirus-mediated delivery of shRNA, we report here the replication-incompetent (dAd/shErbB3) and replication-competent (oAd/shErbB3) oncolytic adenovirus systems that caused efficient and persistent targeting of ErbB3. We demonstrate that the E1A coded by oAd/shErbB, in contrast to dAd/shErbB, caused downregulation of ErbB2 and ErbB3, yielding stronger downregulation of the ErbB3-oncogenic signaling axis in in vitro models of lung and breast cancer. These results were validated by in vivo antitumor efficacy of dAd/shErbB3 and oAd/shErbB3. |
format | Online Article Text |
id | pubmed-9266575 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92665752022-07-09 ErbB3-Targeting Oncolytic Adenovirus Causes Potent Tumor Suppression by Induction of Apoptosis in Cancer Cells Jung, Bo-Kyeong Kim, Young Jun Hong, JinWoo Chang, Han-Gyu Yoon, A-Rum Yun, Chae-Ok Int J Mol Sci Article Cancer is a multifactorial and deadly disease. Despite major advancements in cancer therapy in the last two decades, cancer incidence is on the rise and disease prognosis still remains poor. Furthermore, molecular mechanisms of cancer invasiveness, metastasis, and drug resistance remain largely elusive. Targeted cancer therapy involving the silencing of specific cancer-enriched proteins by small interfering RNA (siRNA) offers a powerful tool. However, its application in clinic is limited by the short half-life of siRNA and warrants the development of efficient and stable siRNA delivery systems. Oncolytic adenovirus-mediated therapy offers an attractive alternative to the chemical drugs that often suffer from innate and acquired drug resistance. In continuation to our reports on the development of oncolytic adenovirus-mediated delivery of shRNA, we report here the replication-incompetent (dAd/shErbB3) and replication-competent (oAd/shErbB3) oncolytic adenovirus systems that caused efficient and persistent targeting of ErbB3. We demonstrate that the E1A coded by oAd/shErbB, in contrast to dAd/shErbB, caused downregulation of ErbB2 and ErbB3, yielding stronger downregulation of the ErbB3-oncogenic signaling axis in in vitro models of lung and breast cancer. These results were validated by in vivo antitumor efficacy of dAd/shErbB3 and oAd/shErbB3. MDPI 2022-06-27 /pmc/articles/PMC9266575/ /pubmed/35806132 http://dx.doi.org/10.3390/ijms23137127 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Jung, Bo-Kyeong Kim, Young Jun Hong, JinWoo Chang, Han-Gyu Yoon, A-Rum Yun, Chae-Ok ErbB3-Targeting Oncolytic Adenovirus Causes Potent Tumor Suppression by Induction of Apoptosis in Cancer Cells |
title | ErbB3-Targeting Oncolytic Adenovirus Causes Potent Tumor Suppression by Induction of Apoptosis in Cancer Cells |
title_full | ErbB3-Targeting Oncolytic Adenovirus Causes Potent Tumor Suppression by Induction of Apoptosis in Cancer Cells |
title_fullStr | ErbB3-Targeting Oncolytic Adenovirus Causes Potent Tumor Suppression by Induction of Apoptosis in Cancer Cells |
title_full_unstemmed | ErbB3-Targeting Oncolytic Adenovirus Causes Potent Tumor Suppression by Induction of Apoptosis in Cancer Cells |
title_short | ErbB3-Targeting Oncolytic Adenovirus Causes Potent Tumor Suppression by Induction of Apoptosis in Cancer Cells |
title_sort | erbb3-targeting oncolytic adenovirus causes potent tumor suppression by induction of apoptosis in cancer cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266575/ https://www.ncbi.nlm.nih.gov/pubmed/35806132 http://dx.doi.org/10.3390/ijms23137127 |
work_keys_str_mv | AT jungbokyeong erbb3targetingoncolyticadenoviruscausespotenttumorsuppressionbyinductionofapoptosisincancercells AT kimyoungjun erbb3targetingoncolyticadenoviruscausespotenttumorsuppressionbyinductionofapoptosisincancercells AT hongjinwoo erbb3targetingoncolyticadenoviruscausespotenttumorsuppressionbyinductionofapoptosisincancercells AT changhangyu erbb3targetingoncolyticadenoviruscausespotenttumorsuppressionbyinductionofapoptosisincancercells AT yoonarum erbb3targetingoncolyticadenoviruscausespotenttumorsuppressionbyinductionofapoptosisincancercells AT yunchaeok erbb3targetingoncolyticadenoviruscausespotenttumorsuppressionbyinductionofapoptosisincancercells |